Expert Interview
A Second View: Discussing the 5-Year COAPT Trial Data on Abbott's MitraClip Mitral Regurgitation device, released at ACC 2023
Ticker(s): ABTInstitution: The University of Tennessee College of Medicine
- Assistant Professor at the University of Tennessee College of Medicine, Co-Director of complex coronary intervention & Chairs the Interventional Cardiology Chronic Total Occlusion Affinity Group at Ascension Saint Thomas Hospital.
- Has treated ~30 patients with mitral regurgitation using MitraClip.
- Clinical and research focus on the management of complex coronary disease, including chronic total occlusions, imaging, physiology, peripheral arterial revascularization, cardiogenic shock, and management of pulmonary embolism.
How does the 5-year data reflect on the use of MitraClip?
Added By: max_adminIs MitraClip on course to become the standard of care for mitral regurgitation?
Added By: max_adminWhat other products are currently available for treating Mitral regurgitation?
Added By: max_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
